S. Fritsch

1.0k total citations
11 papers, 829 citations indexed

About

S. Fritsch is a scholar working on Hematology, Infectious Diseases and Epidemiology. According to data from OpenAlex, S. Fritsch has authored 11 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 2 papers in Infectious Diseases and 2 papers in Epidemiology. Recurrent topics in S. Fritsch's work include Blood Coagulation and Thrombosis Mechanisms (6 papers), Hemophilia Treatment and Research (6 papers) and Platelet Disorders and Treatments (3 papers). S. Fritsch is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (6 papers), Hemophilia Treatment and Research (6 papers) and Platelet Disorders and Treatments (3 papers). S. Fritsch collaborates with scholars based in United States, Austria and Canada. S. Fritsch's co-authors include M. Oh, Bruce M. Ewenstein, P Schroth, Kathelijn Fischer, Victor S. Blanchette, Gerald Spotts, László Endrényi, Peter W. Collins, Sven Björkman and P. Collins and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Vaccine.

In The Last Decade

S. Fritsch

11 papers receiving 801 citations

Peers

S. Fritsch
Lawrence Galitz United States
Grant Langdon United Kingdom
Victor R. Gordeuk United States
Million A. Tegenge United States
S P Dix United States
Michelle E. Roh United States
L. Lin United States
Susan Vogel United States
Lydia L. Benitez United States
George F. Mabeza United States
Lawrence Galitz United States
S. Fritsch
Citations per year, relative to S. Fritsch S. Fritsch (= 1×) peers Lawrence Galitz

Countries citing papers authored by S. Fritsch

Since Specialization
Citations

This map shows the geographic impact of S. Fritsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Fritsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Fritsch more than expected).

Fields of papers citing papers by S. Fritsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Fritsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Fritsch. The network helps show where S. Fritsch may publish in the future.

Co-authorship network of co-authors of S. Fritsch

This figure shows the co-authorship network connecting the top 25 collaborators of S. Fritsch. A scholar is included among the top collaborators of S. Fritsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Fritsch. S. Fritsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Fritz, Richard, Daniel Portsmouth, M. Keith Howard, et al.. (2013). Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population. The Journal of Infectious Diseases. 209(1). 12–23. 24 indexed citations
4.
Ehrlich, Hartmut J., Júlia Singer, S. Fritsch, et al.. (2012). A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals. Clinical Infectious Diseases. 54(7). 946–954. 22 indexed citations
5.
Fischer, Kathelijn, Peter W. Collins, Sven Björkman, et al.. (2011). Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials. Haemophilia. 17(3). 433–438. 36 indexed citations
6.
Björkman, Sven, Victor S. Blanchette, Kathelijn Fischer, et al.. (2010). Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related differences and implications for dose tailoring. Journal of Thrombosis and Haemostasis. 8(4). 730–736. 99 indexed citations
7.
Collins, Peter W., Sven Björkman, Kathelijn Fischer, et al.. (2009). Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. Journal of Thrombosis and Haemostasis. 8(2). 269–275. 147 indexed citations
8.
Collins, P., Victor S. Blanchette, Kathelijn Fischer, et al.. (2008). Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. Journal of Thrombosis and Haemostasis. 7(3). 413–420. 262 indexed citations
9.
Loew-Baselli, Alexandra, Ryszard Konior, Borislava G. Pavlova, et al.. (2006). Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN®: Results of two large phase 3 clinical studies. Vaccine. 24(24). 5256–5263. 51 indexed citations
10.
Endrényi, László, et al.. (1991). Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.. PubMed. 29(10). 394–9. 116 indexed citations
11.
Fritsch, S., et al.. (1984). Simulation of pharmacokinetic behaviour of drug-cyclodextrin complexes.. PubMed. 39(12). 830–4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026